layout image layout image
 
Diabetic Cooking header image

American Diabetic Association Links


Ophthalmologists Warn That Serious, Blinding Eye Diseases May Show No Early Symptoms

Aerpio Appoints Dr. Adrienne Graves to Board of Directors

American Well, Consult A Doctor Unveil iPhone Telehealth Apps

Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain Activity In Fibromyalgia Patients

Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic ...

<< 1 2 3 >>


 

Diabetic Cooking Recommended Products
American Diabetic Association Headlines

Ophthalmologists Warn That Serious, Blinding Eye Diseases May Show No Early Symptoms

SAN FRANCISCO, CA-- - The American Academy of Ophthalmology and EyeCare America , a public-service program of the Foundation of the American Academy of Ophthalmology, urge all Americans to make regular ...

Read more...


Aerpio Appoints Dr. Adrienne Graves to Board of Directors

Aerpio Therapeutics, a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory bowel disease,

Read more...


American Well, Consult A Doctor Unveil iPhone Telehealth Apps

As the American Telemedicine Association conference ( ATA 2012 ) kicks off in San Jose, Calif., American Well Systems and Consult A Doctor are both taking remote care mobile.

Read more...


Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain Activity In Fibromyalgia Patients

Pfizer Inc. announced today the results of studies on Lyrica® capsules CV presented at the American Pain Society Annual Meeting in Honolulu. The studies included exploratory research designed to provide new insight into how Lyrica works in the brains of patients with fibromyalgia.

Read more...


Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic ...

RARITAN, N.J., May 17, 2012 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the results of an investigational Phase 3 study suggesting NUCYNTA® ER (tapentadol) extended-release tablets were ...

Read more...


 
layout image layout image